Dermapharm Holding SE

LSE:0A5J Stock Report

Market Cap: €2.2b

Dermapharm Holding Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Hans-Georg Feldmeier

Chief executive officer

€1.4m

Total compensation

CEO salary percentage59.7%
CEO tenure7.4yrs
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure7.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Hans-Georg Feldmeier's remuneration changed compared to Dermapharm Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

€91m

Jun 30 2024n/an/a

€83m

Mar 31 2024n/an/a

€57m

Dec 31 2023€1m€821k

€62m

Sep 30 2023n/an/a

€95m

Jun 30 2023n/an/a

€123m

Mar 31 2023n/an/a

€146m

Dec 31 2022€1m€800k

€134m

Sep 30 2022n/an/a

€176m

Jun 30 2022n/an/a

€185m

Mar 31 2022n/an/a

€211m

Dec 31 2021€1m€800k

€210m

Sep 30 2021n/an/a

€162m

Jun 30 2021n/an/a

€123m

Mar 31 2021n/an/a

€95m

Dec 31 2020€736k€411k

€86m

Compensation vs Market: Hans-Georg's total compensation ($USD1.41M) is below average for companies of similar size in the UK market ($USD2.38M).

Compensation vs Earnings: Hans-Georg's compensation has been consistent with company performance over the past year.

CEO

Hans-Georg Feldmeier

7.4yrs

Tenure

€1,375,000

Compensation

Dr. Hans-Georg Feldmeier is the Chief Executive Officer and Chairman of the Management Board at Dermapharm Holding SE and also serves as Member of the Management Board from August 2017.

Leadership Team

NamePositionTenureCompensationOwnership
Hans-Georg Feldmeier
CEO & Chairman of the Management Board7.4yrs€1.38mno data
Christof Dreibholz
CFO, Chief Compliance Officer & Member of Management Board2.2yrs€617.00kno data
Andreas Eberhorn
Chief Marketing Officer & Member of Management Board2.3yrs€612.00kno data
Britta Hamberger
Head of Investor Relations & Corporate Communicationsno datano datano data

2.3yrs

Average Tenure

Experienced Management: 0A5J's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lothar Lanz
Independent Member of Supervisory Board7yrs€80.00kno data
Wilhelm Beier
Chairman of the Supervisory Board7.4yrs€80.00kno data
Erwin Kern
Independent Vice Chairman of the Supervisory Board7.4yrs€80.00kno data

7.4yrs

Average Tenure

68yo

Average Age

Experienced Board: 0A5J's board of directors are considered experienced (7.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 15:54
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dermapharm Holding SE is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gerhard OrgonasBerenberg
Daniel WendorffCommerzbank AG
Fabian PiastaJefferies LLC